title: In vitro antimicrobial activity of ten medicinal plants against clinical isolates of oral cancer cases.
abstract: BACKGROUND
  Suppression of immune system in treated cancer patients may lead to secondary infections that obviate the need of antibiotics. In the present study, an attempt was made to understand the occurrence of secondary infections in immuno-suppressed patients along with herbal control of these infections with the following objectives to: (a) isolate the microbial species from the treated oral cancer patients along with the estimation of absolute neutrophile counts of patients (b) assess the in vitro antimicrobial activity medicinal plants against the above clinical isolates.
  
  
  METHODS
  Blood and oral swab cultures were taken from 40 oral cancer patients undergoing treatment in the radiotherapy unit of Regional Cancer Institute, Pt. B.D.S. Health University,Rohtak, Haryana. Clinical isolates were identified by following general microbiological, staining and biochemical methods. The absolute neutrophile counts were done by following the standard methods. The medicinal plants selected for antimicrobial activity analysis were Asphodelus tenuifolius Cav., Asparagus racemosus Willd., Balanites aegyptiaca L., Cestrum diurnum L., Cordia dichotoma G. Forst, Eclipta alba L., Murraya koenigii (L.) Spreng. , Pedalium murex L., Ricinus communis L. and Trigonella foenum graecum L. The antimicrobial efficacy of medicinal plants was evaluated by modified Kirby-Bauer disc diffusion method. MIC and MFC were investigated by serial two fold microbroth dilution method.
  
  
  RESULTS
  Prevalent bacterial pathogens isolated were Staphylococcus aureus (23.2%), Escherichia coli (15.62%), Staphylococcus epidermidis (12.5%), Pseudomonas aeruginosa (9.37%), Klebsiella pneumonia (7.81%), Proteus mirabilis (3.6%), Proteus vulgaris (4.2%) and the fungal pathogens were Candida albicans (14.6%), Aspergillus fumigatus (9.37%). Out of 40 cases, 35 (87.5%) were observed as neutropenic. Eight medicinal plants (A. tenuifolius, A. racemosus, B. aegyptiaca, E. alba, M. koenigii, P. murex R. communis and T. foenum graecum) showed significant antimicrobial activity (P < .05) against most of the isolates. The MIC and MFC values were ranged from 31 to 500 μg/ml. P. aeruginosa was observed highest susceptible bacteria (46.6%) on the basis of susceptible index.
  
  
  CONCLUSIONS
  It can be concluded that treated oral cancer patients were neutropenic and prone to secondary infection of microbes. The medicinal plant can prove as effective antimicrobial agent to check the secondary infections in treated cancer patients.
authors: Department of Genetics, M. D. University, Rohtak-124001, Haryana, India.
authors: Manju
authors: M
authors: Panghal
authors: Vivek
authors: V
authors: Kaushal
authors: Jaya P
authors: JP
authors: Yadav
references: J Ethnopharmacol. 1997 Oct;58(2):75-83
references: 9406894
references: J Nat Prod. 1994 Jun;57(6):858-61
references: 7931371
references: Pharmacotherapy. 1999 Aug;19(8 Pt 2):120S-128S; discussion 133S-137S
references: 10456609
references: J Ethnopharmacol. 1996 Jan;50(1):27-34
references: 8778504
references: Hematol Oncol. 2009 Sep;27(3):107-14
references: 19569253
references: Antimicrob Agents Chemother. 2003 Sep;47(9):2859-63
references: 12936985
references: Molecules. 2009 Feb 04;14(2):586-97
references: 19214149
references: Appl Environ Microbiol. 1998 Feb;64(2):520-5
references: 9464387
references: J Nat Prod. 1993 Aug;56(8):1276-80
references: 8229012
references: Clin Microbiol Rev. 1999 Oct;12(4):564-82
references: 10515903
references: Cancer. 2005 Jul 1;104(1):205-12
references: 15880433
references: Cancer. 2003 Jan 15;97(2):419-24
references: 12518366
references: Plant Cell. 1994 Sep;6(9):1191-1192
references: 12244269
references: Clin Infect Dis. 2002 Mar 15;34(6):730-51
references: 11850858
references: Ann Allergy Asthma Immunol. 1996 Sep;77(3):167-73; quiz 173-5
references: 8814039
references: Am J Clin Pathol. 1966 Apr;45(4):493-6
references: 5325707
references: Methods. 2007 Aug;42(4):321-4
references: 17560319
references: Phytomedicine. 2008 Aug;15(8):639-52
references: 18599280
references: Phytochemistry. 1997 May;45(2):321-4
references: 9162177
references: J Ethnopharmacol. 1998 Sep;62(2):183-93
references: 9741890
references: J Clin Oncol. 2000 Aug;18(16):3038-51
references: 10944139
references: Clin Infect Dis. 2004 Jul 15;39 Suppl 1:S32-7
references: 15250018
references: Phytother Res. 2000 Mar;14(2):118-9
references: 10685109
references: J Pharm Pharmacol. 1994 Nov;46(11):892-5
references: 7897594
references: Infection. 1999;27 Suppl 2:S29-31
references: 10885824
references: J Ethnopharmacol. 1998 Feb;60(1):1-8
references: 9533426
references: Clin Infect Dis. 2005 Apr 1;40 Suppl 4:S246-52
references: 15768330
references: J Med Microbiol. 2006 Oct;55(Pt 10):1447-1451
references: 17005796
references: J Antimicrob Chemother. 2008 Mar;61(3):721-8
references: 18218645
references: J Ethnopharmacol. 2005 Oct 31;102(1):123-6
references: 16159702
references: J Ethnopharmacol. 1997 Mar;56(1):81-7
references: 9147258
references: Clin Infect Dis. 2007 Dec 15;45(12):1602-9
references: 18190323
references: Indian J Pharm Sci. 2009 May;71(3):342-3
references: 20490311